{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:50:46Z","timestamp":1793962246949,"version":"4.8.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":48,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>\u2018Breast cancer gene-expression miner\u2019 (bc-GenExMiner) is a breast cancer\u2013associated web portal (http:\/\/bcgenex.ico.unicancer.fr). Here, we describe the development of a new statistical mining module, which permits several differential gene expression analyses, i.e. \u2018Expression\u2019 module. Sixty-two breast cancer cohorts and one healthy breast cohort with their corresponding clinicopathological information are included in bc-GenExMiner v4.5 version. Analyses are based on microarray or RNAseq transcriptomic data. Thirty-nine differential gene expression analyses, grouped into 13 categories, according to clinicopathological and molecular characteristics (\u2018Targeted\u2019 and \u2018Exhaustive\u2019) and gene expression (\u2018Customized\u2019), have been developed. Output results are visualized in four forms of plots. This new statistical mining module offers, among other things, the possibility to compare gene expression in healthy (cancer-free), tumour-adjacent and tumour tissues at once and in three triple-negative breast cancer subtypes (i.e. C1: molecular apocrine tumours; C2: basal-like tumours infiltrated by immune suppressive cells and C3: basal-like tumours triggering an ineffective immune response). Several validation tests showed that bioinformatics process did not alter the pathobiological information contained in the source data. In this work, we developed and demonstrated that bc-GenExMiner \u2018Expression\u2019 module can be used for exploratory and validation purposes.<\/jats:p>\n               <jats:p>Database URL: http:\/\/bcgenex.ico.unicancer.fr<\/jats:p>","DOI":"10.1093\/database\/baab007","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T20:26:04Z","timestamp":1611865564000},"source":"Crossref","is-referenced-by-count":158,"title":["bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses"],"prefix":"10.1093","volume":"2021","author":[{"given":"Pascal","family":"J\u00e9z\u00e9quel","sequence":"first","affiliation":[{"name":"Unit\u00e9 de Bioinfomique, Institut de Canc\u00e9rologie de l\u2019Ouest, Bd Jacques Monod, Saint Herblain Cedex 44805, France"},{"name":"CRCINA Team 8, UMR 1232 INSERM, Universit\u00e9 de Nantes, Universit\u00e9 d\u2019Angers, Institut de Recherche en Sant\u00e9-Universit\u00e9 de Nantes, 8 Quai Moncousu\u2014BP 70721, Nantes 44007, France"},{"name":"SIRIC ILIAD, Institut de Recherche en Sant\u00e9-Universit\u00e9 de Nantes, 8 Quai Moncousu-BP 70721, Nantes 44007, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Gouraud","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Bioinfomique, Institut de Canc\u00e9rologie de l\u2019Ouest, Bd Jacques Monod, Saint Herblain Cedex 44805, France"},{"name":"SIRIC ILIAD, Institut de Recherche en Sant\u00e9-Universit\u00e9 de Nantes, 8 Quai Moncousu-BP 70721, Nantes 44007, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadoua","family":"Ben Azzouz","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Bioinfomique, Institut de Canc\u00e9rologie de l\u2019Ouest, Bd Jacques Monod, Saint Herblain Cedex 44805, France"},{"name":"SIRIC ILIAD, Institut de Recherche en Sant\u00e9-Universit\u00e9 de Nantes, 8 Quai Moncousu-BP 70721, Nantes 44007, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Gu\u00e9rin-Charbonnel","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Bioinfomique, Institut de Canc\u00e9rologie de l\u2019Ouest, Bd Jacques Monod, Saint Herblain Cedex 44805, France"},{"name":"SIRIC ILIAD, Institut de Recherche en Sant\u00e9-Universit\u00e9 de Nantes, 8 Quai Moncousu-BP 70721, Nantes 44007, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4997-3888","authenticated-orcid":false,"given":"Philippe P","family":"Juin","sequence":"additional","affiliation":[{"name":"CRCINA Team 8, UMR 1232 INSERM, Universit\u00e9 de Nantes, Universit\u00e9 d\u2019Angers, Institut de Recherche en Sant\u00e9-Universit\u00e9 de Nantes, 8 Quai Moncousu\u2014BP 70721, Nantes 44007, France"},{"name":"SIRIC ILIAD, Institut de Recherche en Sant\u00e9-Universit\u00e9 de Nantes, 8 Quai Moncousu-BP 70721, Nantes 44007, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Lasla","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Bioinfomique, Institut de Canc\u00e9rologie de l\u2019Ouest, Bd Jacques Monod, Saint Herblain Cedex 44805, France"},{"name":"SIRIC ILIAD, Institut de Recherche en Sant\u00e9-Universit\u00e9 de Nantes, 8 Quai Moncousu-BP 70721, Nantes 44007, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Campone","sequence":"additional","affiliation":[{"name":"CRCINA Team 8, UMR 1232 INSERM, Universit\u00e9 de Nantes, Universit\u00e9 d\u2019Angers, Institut de Recherche en Sant\u00e9-Universit\u00e9 de Nantes, 8 Quai Moncousu\u2014BP 70721, Nantes 44007, France"},{"name":"SIRIC ILIAD, Institut de Recherche en Sant\u00e9-Universit\u00e9 de Nantes, 8 Quai Moncousu-BP 70721, Nantes 44007, France"},{"name":"Oncologie M\u00e9dicale, Institut de Canc\u00e9rologie de l\u2019Ouest\u2014Ren\u00e9 Gauducheau, Bd Jacques Monod, Saint Herblain 44805, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"2021022002280012500_R1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10549-011-1457-7","article-title":"bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer","volume":"131","author":"J\u00e9z\u00e9quel","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"2021022002280012500_R2","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bas060","article-title":"bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses","volume":"2013","author":"J\u00e9z\u00e9quel","year":"2013","journal-title":"Database (Oxford)"},{"key":"2021022002280012500_R3","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-015-0550-y","article-title":"Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response","volume":"17","author":"J\u00e9z\u00e9quel","year":"2015","journal-title":"Breast Cancer Res."},{"key":"2021022002280012500_R4","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800484","article-title":"iTRAQ-based quantitative proteomic analysis strengthens transcriptomic subtyping of triple-negative breast cancer tumors","volume":"19","author":"J\u00e9z\u00e9quel","year":"2019","journal-title":"Proteomics"},{"key":"2021022002280012500_R5","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-019-1148-6","article-title":"Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications","volume":"21","author":"J\u00e9z\u00e9quel","year":"2019","journal-title":"Breast Cancer Res."},{"key":"2021022002280012500_R6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"2021022002280012500_R7","doi-asserted-by":"crossref","first-page":"13550","DOI":"10.1073\/pnas.0506230102","article-title":"An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patients survival","volume":"102","author":"Miller","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021022002280012500_R8","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5952836","article-title":"TP53 mutations promote immunogenic activity in breast cancer","volume":"2019","author":"Liu","year":"2019","journal-title":"J. Oncol."},{"key":"2021022002280012500_R9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028403","article-title":"Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures","volume":"6","author":"Karn","year":"2011","journal-title":"PLoS One"},{"key":"2021022002280012500_R10","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021022002280012500_R11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1634\/theoncologist.2012-0397","article-title":"Molecular characterization of basal-like and non-basal-like triple-negative breast cancer","volume":"18","author":"Prat","year":"2013","journal-title":"Oncologist"},{"key":"2021022002280012500_R12","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1158\/0008-5472.CAN-09-4120","article-title":"FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer","volume":"70","author":"Ray","year":"2010","journal-title":"Cancer Res."},{"key":"2021022002280012500_R13","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J. Clin. Invest."},{"key":"2021022002280012500_R14","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","article-title":"Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer","volume":"21","author":"Burstein","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"2021022002280012500_R15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"2021022002280012500_R16","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-015-0131-9","article-title":"The Sweden Cancerome Analysis Network - Breast (SCAN-B) initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine","volume":"7","author":"Saal","year":"2015","journal-title":"Genome Med."},{"key":"2021022002280012500_R17","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt214","article-title":"The subread aligner: fast, accurate and scalable read mapping by seed-and-vote","volume":"41","author":"Liao","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"2021022002280012500_R18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2006","journal-title":"Biostatistics"},{"key":"2021022002280012500_R19","article-title":"Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches","volume":"129","author":"Ben Azzouz","year":"2020","journal-title":"Comput. Biol. Med."},{"key":"2021022002280012500_R20","doi-asserted-by":"crossref","DOI":"10.1186\/s12920-015-0129-6","article-title":"Development and verification of PAM50-based Prosigna breast cancer gene signature assay","volume":"8","author":"Wallden","year":"2015","journal-title":"BMC Med. Genomics"},{"key":"2021022002280012500_R21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2217\/14796694.5.2.259","article-title":"The TGF-beta paradox in human cancer: an update","volume":"5","author":"Tian","year":"2009","journal-title":"Future Oncol."},{"key":"2021022002280012500_R22","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003277","article-title":"TGF-beta biology in mammary development and breast cancer","volume":"3","author":"Moses","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2021022002280012500_R23","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/141747","article-title":"Two faces of TGF-beat1 in breast cancer","volume":"2014","author":"Zarzynska","year":"2014","journal-title":"Mediators Inflamm."},{"key":"2021022002280012500_R24","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.breast.2013.07.005","article-title":"p53 in breast cancer subtypes and new insights into response to chemotherapy","volume":"22","author":"Bertheau","year":"2013","journal-title":"Breast"},{"key":"2021022002280012500_R25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10549-018-4753-7","article-title":"Mutant p53 in breast cancer: potential as a therapeutic target and biomarker","volume":"170","author":"Duffy","year":"2018","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Database"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/database\/article-pdf\/doi\/10.1093\/database\/baab007\/36325766\/baab007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/database\/article-pdf\/doi\/10.1093\/database\/baab007\/36325766\/baab007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T06:16:07Z","timestamp":1613888167000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/database\/article\/doi\/10.1093\/database\/baab007\/6143043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1093\/database\/baab007","relation":{},"ISSN":["1758-0463"],"issn-type":[{"value":"1758-0463","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2021,1,1]]},"article-number":"baab007"}}